As of 2024-12-12, the Intrinsic Value of Novartis AG (NOVN.SW) is
87.01 CHF. This NOVN.SW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 87.94 CHF, the upside of Novartis AG is
-1.10%.
The range of the Intrinsic Value is 55.44 - 194.94 CHF
87.01 CHF
Intrinsic Value
NOVN.SW Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
55.44 - 194.94 |
87.01 |
-1.1% |
| DCF (Growth 10y) |
62.19 - 201.15 |
93.88 |
6.7% |
| DCF (EBITDA 5y) |
34.98 - 48.88 |
41.07 |
-53.3% |
| DCF (EBITDA 10y) |
45.92 - 64.87 |
54.14 |
-38.4% |
| Fair Value |
197.65 - 197.65 |
197.65 |
124.75% |
| P/E |
76.91 - 163.81 |
110.30 |
25.4% |
| EV/EBITDA |
66.90 - 94.34 |
78.56 |
-10.7% |
| EPV |
111.45 - 169.95 |
140.70 |
60.0% |
| DDM - Stable |
83.94 - 362.30 |
223.12 |
153.7% |
| DDM - Multi |
47.65 - 153.73 |
72.03 |
-18.1% |
NOVN.SW Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
172,053.73 |
| Beta |
0.81 |
| Outstanding shares (mil) |
1,956.49 |
| Enterprise Value (mil) |
187,630.45 |
| Market risk premium |
5.10% |
| Cost of Equity |
6.28% |
| Cost of Debt |
4.25% |
| WACC |
5.97% |